Choosing a real-world evidence platform: what actually matters
Most RWE platforms can generate analyses. Few deliver results that can be validated, reused, and applied with confidence.
Resources and expert insights
Check out the latest thinking from our team — explore our blog, read white papers, watch videos, and more.
Viewing results for:
Filter by type
Filter by topic
Search
Read more
How real-world evidence supports oncology drug development
RWE in oncology must stand up to regulatory, HTA, and access scrutiny—requiring decision‑grade, multimodal, globally relevant data.
How to choose a medical research data platform (and why most pharma strategies fail)
Why most medical research data platform strategies fail — based on a recent Frontiers review, and what it takes to scale AI and RWE.
How real-world data and AI can shorten clinical trial timelines by 6-12 months
Clinical trial delays often start in study design. Real‑world data and AI help teams reduce amendments, improve recruitment, and avoid 6-12 months of delay.
How AI makes European Health Data Space data usable
AI is making data accessed through the EHDS usable—turning fragmented access into secure, scalable workflows.
EHDS for pharma: A complete guide
EHDS introduces a new framework for pharma data access, affecting trials, real-world evidence, AI, and speed to market.
How real-world data helps reduce clinical trial risk
Learn how fit-for-purpose real-world data helps pressure-test assumptions, improve recruitment, and strengthen submission readiness.
Enabling AI‑ready oncology cohorts from hospital data across indications and regions
Accessing hospital clinical and imaging data to build AI‑ready oncology cohorts at scale across indications and regions.
Building global real-world evidence for a rare autoimmune hematologic disease
Global real‑world dataset across 300+ patients, enabling real‑world treatment insights for decision‑making.